Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections

Ma, WJ; Gong, ZM; Abu-Sbeih, H; Peng, YZ; Peng, FD; Zou, FW; Charabaty, A; Okhuysen, PC; McQuade, JL; Altan, M; Zhang, HC; Thomas, AS; Wang, YH

Wang, YH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, 1515 Holcombe Blvd,Unit 1466, Houston, TX 77030 USA.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021; 44 (8): 402

Abstract

Background and Objective: Immune-mediated diarrhea and colitis (IMDC) is a common adverse event in cancer patients receiving immune checkpoint inhibit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索